TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. Chang Lisa
2021-02-17T13:53:31+00:00
Industrial Bank of Taiwan, China Development Industrial Bank, Daiwa Securities Group Inc., and Diamond BioFund Inc. raise over ten billion NTD for Biotech. Chang Lisa
2021-02-17T14:29:53+00:00
